In this free webinar, attendees will gain insights into the benefits of consolidating mRNA manufacturing processes with a single, integrated CDMO to streamline operations, reduce supply chain complexity and minimize the risk of disruptions. Learn how partnering with an integrated CDMO eliminates the need for coordination among multiple vendors, optimizing regulatory submissions, mitigating risks and enhancing the readiness of mRNA products for market entry. The featured speaker will discuss how a CDMO's comprehensive solution offers cost savings, improved quality control and accelerated timelines, ultimately advancing the success and accessibility of mRNA therapies for patients worldwide.
TORONTO, April 29, 2024 /PRNewswire-PRWeb/ -- Discover an informative webinar on the benefits of uniting with a contract development and manufacturing organization (CDMO) for nucleic acid-based therapeutics production.
The development and commercialization of nucleic acid-based therapeutics, including messenger RNA (mRNA), plasmid DNA (pDNA) and lipid nanoparticles (LNP) drug products, hold immense promise for revolutionizing healthcare. However, navigating the intricate landscape of their manufacturing processes poses significant challenges, often requiring coordination among multiple vendors.
This webinar explores the complexities inherent in managing diverse vendors for bioprocessing and emphasizes the benefits of consolidating operations with a single, integrated CDMO. Attendees of this event will gain insights into overcoming current program challenges while maximizing efficiency and product quality.
The webinar will also highlight key capabilities to seek out in an integrated CDMO guiding nucleic acid products from development through to commercial manufacturing, eliminating the need for multi-vendor coordination and ensuring robust supply chain continuity.
Key topics include leveraging a CDMO's expertise, facilities and technology to optimize regulatory submissions, mitigate supply chain risks and enhance commercial manufacturing readiness. Attendees will learn how a unified approach from development to production can lower costs, reduce the risk of disruptions and expedite the progression of mRNA therapeutics from concept to market.
Register for this webinar to explore the advantages of consolidating manufacturing processes and discover how a singular, integrated approach can propel the advancement of mRNA manufacturing towards clinical success and widespread patient impact.
Join featured speaker Jessica Madigan, Director of Business Development, Nucleic Acid Modalities, BIOVECTRA, for the live webinar on Wednesday, May 15, 2024, at 2pm EDT (11am PDT).
For more information, or to register for this event, visit Streamlining the mRNA Manufacturing Supply Chain: Challenges and Solutions Provided by CDMOs.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Ayesha Rashid, Xtalks, +1 (416) 977-6555 x272, [email protected], https://xtalks.com
SOURCE Xtalks
Share this article